Cargando…

Correction: Considerations in the management of hereditary angioedema due to C1-INH deficiency in women of childbearing age

Detalles Bibliográficos
Autores principales:	Hsu, Florence Ida, Lumry, William, Riedl, Marc, Tachdjian, Raffi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441103/ https://www.ncbi.nlm.nih.gov/pubmed/36057583 http://dx.doi.org/10.1186/s13223-022-00714-x

Ejemplares similares

Considerations in the management of hereditary angioedema due to C1-INH deficiency in women of childbearing age
por: Hsu, Florence Ida, et al.
Publicado: (2022)

A Comprehensive Management Approach in Pediatric and Adolescent Patients With Hereditary Angioedema
por: Tachdjian, Raffi, et al.
Publicado: (2023)

Searching for Genetic Biomarkers for Hereditary Angioedema Due to C1-Inhibitor Deficiency (C1-INH-HAE)
por: Parsopoulou, Faidra, et al.
Publicado: (2022)

Correction to: The International/Canadian Hereditary Angioedema Guideline
por: Betschel, Stephen, et al.
Publicado: (2020)

A patient with hereditary angioedema (HAE) with normal C1-INH and SLE with pregnancy
por: Taha, Omar S., et al.
Publicado: (2022)

Psychometric study of the SF-36v2 in hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE)
por: Palao-Ocharan, Paola, et al.
Publicado: (2022)

Analysis of icatibant for the treatment of laryngeal hereditary angioedema attacks in the FAST-3 study
por: Yang, William, et al.
Publicado: (2014)

Hereditary Angioedema: The Economics of Treatment of an Orphan Disease
por: Lumry, William Raymond
Publicado: (2018)

Clinical and genetic features of hereditary angioedema with and without C1‐inhibitor (C1‐INH) deficiency in Japan
por: Hashimura, Chinami, et al.
Publicado: (2021)

Lanadelumab for the Prophylactic Treatment of Hereditary Angioedema with C1 Inhibitor Deficiency: A Review of Preclinical and Phase I Studies
por: Busse, Paula J., et al.
Publicado: (2018)

Correction to: Content validation and psychometric evaluation of the Angioedema Quality of Life Questionnaire for hereditary angioedema
por: Vanya, Magdalena, et al.
Publicado: (2023)

Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks
por: Riedl, Marc A., et al.
Publicado: (2020)

Advances in Hereditary Angioedema: The Prevention of Angioedema Attacks With Subcutaneous C1-Inhibitor Replacement Therapy
por: Lumry, William, et al.
Publicado: (2020)

Hereditary angioedema with C1 inhibitor (C1-INH) deficit: the strength of recognition (51 cases)
por: Fragnan, N.T.M.L., et al.
Publicado: (2018)

165 Early Versus Delayed Treatment of Swelling Attacks with Icatibant, a Bradykinin 2 Receptor Antagonist in Patients With Hereditary Angioedema due to C1-INH Deficiency
por: Bork, Konrad, et al.
Publicado: (2012)

Correction to: A case of hereditary angioedema due to C(1)-inhibitor deficiency with recurrent abdominal pain diagnosed 40 years after the occurrence of the initial symptom
por: Honda, Daisuke, et al.
Publicado: (2021)

Long‐term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study
por: Banerji, Aleena, et al.
Publicado: (2021)

Pediatric hereditary angioedema due to C1-inhibitor deficiency
por: Farkas, Henriette
Publicado: (2010)

Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study
por: Lumry, William R., et al.
Publicado: (2021)

Impact of lanadelumab on health‐related quality of life in patients with hereditary angioedema in the HELP study
por: Lumry, William R., et al.
Publicado: (2020)

Correction to: Mitigating Disparity in Healthcare Resources Between Countries for Management of Hereditary Angioedema
por: Jindal, Ankur Kumar, et al.
Publicado: (2021)

Hereditary Angioedema Therapy: Kallikrein Inhibition and Bradykinin Receptor Antagonism
por: Riedl, Marc
Publicado: (2010)

Individual approach to long-term therapy in patients with hereditary angioedema (HAE-C1-INH): A case series
por: Andarawewa, S., et al.
Publicado: (2022)

The Global Registry for Hereditary Angioedema due to C1-Inhibitor Deficiency
por: Zanichelli, Andrea, et al.
Publicado: (2021)

Correction to: A Germany-wide survey study on the patient journey of patients with hereditary angioedema
por: Magerl, Markus, et al.
Publicado: (2021)

Recombinant Human C1 Esterase Inhibitor in the Management of Hereditary Angioedema
por: Riedl, Marc
Publicado: (2015)

WAO Guideline for the Management of Hereditary Angioedema
por: Craig, Timothy, et al.
Publicado: (2012)

Practicalities of a reduced volume formulation of a C1-INH concentrate for the treatment of hereditary angioedema: real-life experience
por: Dempster, John
Publicado: (2018)

Correction: A Nationwide Study of Norwegian Patients with Hereditary Angioedema with C1 Inhibitor Deficiency Identified Six Novel Mutations in SERPING1
por: Johnsrud, Irene, et al.
Publicado: (2015)

The influence of trigger factors on hereditary angioedema due to C1-inhibitor deficiency
por: Zotter, Zsuzsanna, et al.
Publicado: (2014)

The Role of Bradykinin Receptors in Hereditary Angioedema Due to C1-Inhibitor Deficiency
por: Dyga, Wojciech, et al.
Publicado: (2022)

Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema
por: Craig, Timothy, et al.
Publicado: (2017)

Clinical Characteristics and Management of Angioedema Attacks in Polish Adult Patients with Hereditary Angioedema Due to C1-Inhibitor Deficiency
por: Piotrowicz-Wójcik, Katarzyna, et al.
Publicado: (2021)

A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy
por: Zanichelli, Andrea, et al.
Publicado: (2015)

A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy
por: Zanichelli, Andrea, et al.
Publicado: (2015)

Hereditary angioedema
por: Lesser, Helen, et al.
Publicado: (2021)

Hereditary Angioedema
por: Banerjee, Anjali, et al.
Publicado: (2023)

Effectiveness of C1-INH therapy in angiotensin converting enzyme inhibitor induced angioedema
por: Kovaltchouk, Uliana, et al.
Publicado: (2021)

Ecallantide is a novel treatment for attacks of hereditary angioedema due to C1 inhibitor deficiency
por: Farkas, Henriette, et al.
Publicado: (2011)

Home treatment with conestat alfa in attacks of hereditary angioedema due to C1-inhibitor deficiency
por: Farkas, Henriette, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_a7i8nn1oguas7a7nnj46rhuhtf